CSMED Stock Overview
CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CS Medica A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 6.32 |
| 52 Week High | DKK 17.99 |
| 52 Week Low | DKK 3.05 |
| Beta | -0.98 |
| 11 Month Change | -20.02% |
| 3 Month Change | -50.79% |
| 1 Year Change | 17.39% |
| 33 Year Change | -15.36% |
| 5 Year Change | n/a |
| Change since IPO | -40.65% |
Recent News & Updates
Shareholder Returns
| CSMED | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | -15.6% | -1.5% | -1.4% |
| 1Y | 17.4% | 38.6% | 20.7% |
Return vs Industry: CSMED underperformed the Swedish Pharmaceuticals industry which returned 44.3% over the past year.
Return vs Market: CSMED underperformed the Swedish Market which returned 25.9% over the past year.
Price Volatility
| CSMED volatility | |
|---|---|
| CSMED Average Weekly Movement | 12.2% |
| Pharmaceuticals Industry Average Movement | 11.0% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SE Market | 10.9% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: CSMED's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: CSMED's weekly volatility has decreased from 21% to 12% over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 9 | Lone Henriksen | www.cs-medica.com |
CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis. It offers gels for psoriasis, arthritis, protective nasal, and wound healing; and CBD anti-hair loss serum, as well as sleep nasal sprays and pain patches. The company primarily offers its products under the CANNASEN brand name.
CS Medica A/S Fundamentals Summary
| CSMED fundamental statistics | |
|---|---|
| Market cap | DKK 55.91m |
| Earnings (TTM) | -DKK 12.31m |
| Revenue (TTM) | DKK 4.67m |
18.7x
P/S Ratio-7.1x
P/E RatioIs CSMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CSMED income statement (TTM) | |
|---|---|
| Revenue | DKK 4.67m |
| Cost of Revenue | DKK 2.85m |
| Gross Profit | DKK 1.81m |
| Other Expenses | DKK 14.12m |
| Earnings | -DKK 12.31m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 14, 2024
| Earnings per share (EPS) | -0.89 |
| Gross Margin | 38.81% |
| Net Profit Margin | -263.84% |
| Debt/Equity Ratio | 676.5% |
How did CSMED perform over the long term?
See historical performance and comparison